WP
AZN icon

WealthShield Partners’s AstraZeneca AZN Stock Holding History

WealthShield Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,175
Closed -$232K – 396
2026
Q1 		$232K Buy
1,175
+3
+0.3% +$578 0.03% 322
2025
Q4 		$215K Buy
+1,172
New +$206K 0.02% 330
2021
Q3 		– Sell
-684
Closed -$82K – 277
2021
Q2 		$82K Sell
684
-90
-12% -$9.87K 0.01% 389
2021
Q1 		$77K Buy
+774
New +$77.8K 0.01% 382

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $148B AUM
PP
Prudential plc London, England, United Kingdom $18.4B AUM 23.98% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

WealthShield Partners's AZN Position: Q2 2026 in Review

WealthShield Partners sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,175 shares — an estimated $232K sold.

WealthShield Partners first reported a position in AZN in Q1 2021 and held it in 4 quarters. The position peaked at $232K in Q1 2026. 1,280 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • WealthShield Partners reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • WealthShield Partners sold 1,175 AstraZeneca shares in Q2 2026, an estimated $232K.
  • WealthShield Partners first reported a position in AstraZeneca in Q1 2021 and held it in 4 quarters.
  • WealthShield Partners's AstraZeneca position peaked at $232K in Q1 2026.
  • 1,280 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on WealthShield Partners's 13F filing for Q2 2026, filed 12 Aug 2026.